Risk of Non-melanoma Skin Cancer in Patients with Chronic Kidney Disease and its Relationship to Uraemic Pruritus

被引：16

作者：

Wang, Chia-Chen ^{[1
,2
,3
]}

Tang, Chao-Hsiun ^{[4
]}

Huang, Siao-Yuan ^{[4
]}

Huang, Kuan-Chih ^{[4
]}

Sue, Yuh-Mou ^{[5
,6
]}

机构：

[1] Cardinal Tien Hosp, Dept Dermatol, New Taipei, Taiwan

[2] Cardinal Tien Hosp, Dept Med Res, New Taipei, Taiwan

[3] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan

[4] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan

[5] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, 5th Floor,111,Sect 3,Xing Long Rd, Taipei 116, Taiwan

[6] Taipei Med Univ, Sch Med, Div Nephrol, Coll Med,Dept Internal Med, Taipei, Taiwan

来源：

ACTA DERMATO-VENEREOLOGICA | 2017年 / 97卷 / 10期

关键词：

non-melanoma skin cancer; chronic kidney disease; uraemic pruritus; epidemiology; POPULATION-BASED COHORT; CKD; INFLAMMATION; HEMODIALYSIS; ASSOCIATION; NATIONWIDE; DIALYSIS; SYSTEM; DAMAGE;

D O I：

10.2340/00015555-2762

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This study investigated the risk of non-melanoma skin cancer (NMSC) in pre-dialysis patients with chronic kidney disease (CKD) and explored associated risk factors. A population-based cohort of 1,515,858 Taiwanese CKD patients was included. The standardized incidence ratio (SIR) for incident NMSC was determined. Compared with the general population, a 1.14-fold risk of NMSC was found in the CKD cohort. NMSC risk was significant in patients with pre-dialysis stage 5 CKD and anaemia (1.48-fold), and in those with uraemic pruritus after long-term antihistamine treatment (1.38-fold). A higher SIR for NMSC was found in younger patients with CKD (age < 70 years, 1.34-fold; age 20-39 years, 1.63-fold), stage 5 CKD with anaemia (age < 70 years, 2.09-fold), and uraemic pruritus (age < 70 years, 2.22-fold). Pre-dialysis patients with CKD are at higher risk of NMSC, especially those with advanced-stage CKD, and those with uraemic pruritus.

引用

页码：1230 / 1234

页数：5

共 50 条

[41] Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer
Barber, Kirk
Searles, Gordon E.
Vender, Ronald
Teoh, Hwee
Ashkenas, John
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (03) : 216 - 226
[42] Dermoscopy of melanoma and non-melanoma skin cancer
Babino, G.
Lallas, A.
Longo, C.
Moscarella, E.
Alfano, R.
Argenziano, G.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2015, 150 (05): : 507 - 519
[43] Prediction of the Occurrence of Melanoma and Non-melanoma Skin Cancer in Patients with Vitiligo
Hammoud, Shedia M.
Kruis, Rosalie W. J.
Sigurdsson, Vigfus
ACTA DERMATO-VENEREOLOGICA, 2016, 96 (01) : 106 - 107
[44] Non-melanoma skin cancer is associated with increased risk of fractures
Anderson, E.
Stefanick, M.
Desai, M.
Kubo, J.
Wysong, A.
Tang, J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S53 - S53
[45] Non-melanoma skin cancer incidence and risk factors after kidney transplantation: A Canadian experience
Comeau, Sherry
Jensen, Loinse
Cockfield, Sandra M.
Sapijaszko, Mariusz
Gourishankar, Sita
TRANSPLANTATION, 2008, 86 (04) : 535 - 541
[46] Radiotherapy for Non-Melanoma Skin Cancer
Khanh Vu
Tai, Patricia
Au, Joseph S. K.
CURRENT CANCER THERAPY REVIEWS, 2016, 12 (02) : 110 - 123
[47] MicroRNA in non-melanoma skin cancer
Sand, Michael
Sand, Daniel
Altmeyer, Peter
Bechara, Falk G.
CANCER BIOMARKERS, 2012, 11 (06) : 253 - 257
[48] Risk of Non-Melanoma Skin Cancer in Connective Tissue Disease and the Impact of Immunosuppressive Therapy
Gunawardane, Nilanthi D.
Dontsi, Makdine
Lyon, Liisa L.
JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (05) : 519 - 523
[49] Photoimmunology of non-melanoma skin cancer
Streilein, JW
CANCER SURVEYS, 1996, 26 : 207 - 217
[50] Cetuximab in non-melanoma skin cancer
Wollina, Uwe
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956

← 1 2 3 4 5 →